Related content

Efficacy of chemotherapy plus gefitinib treatment in advanced nonsmallcell lung cancer patients following acquired resistance to gefitinib

By    

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 875-878

Spandidos Publications

Access to resources Recommend Favorite

Rechallenge with pemetrexed-based chemotherapy improves the survival of patients with advanced non-squamous non-smallcell lung cancer

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 953-959

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of tyrosine kinase inhibitors in nonsmallcell lung cancer patients undergoing dose reduction and those with a low body surface area

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 604-608

Spandidos Publications

Access to resources Recommend Favorite

Misjudgement of gefitinib efficacy in patients with central non-smallcell lung cancer due to obstructive atelectasis caused by stereotactic radiotherapy

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 535-538

Spandidos Publications

Access to resources Recommend Favorite

The concentration of erlotinib in the cerebrospinal fluid of patients with brain metastasis from nonsmallcell lung cancer

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 1, 2014-01 ,pp. : 116-120

Spandidos Publications

Access to resources Recommend Favorite